Literature DB >> 30342710

Glutathione as a Marker for Human Disease.

Garrett Teskey1, Rachel Abrahem1, Ruoqiong Cao2, Karo Gyurjian3, Hicret Islamoglu4, Mariana Lucero1, Andrew Martinez1, Erik Paredes1, Oscar Salaiz3, Brittanie Robinson3, Vishwanath Venketaraman5.   

Abstract

Glutathione (GSH), often referred to as "the master antioxidant," participates not only in antioxidant defense systems, but many metabolic processes, and therefore its role cannot be overstated. GSH deficiency causes cellular risk for oxidative damage and thus as expected, GSH imbalance is observed in a wide range of pathological conditions including tuberculosis (TB), HIV, diabetes, cancer, and aging. Consequently, it is not surprising that GSH has attracted the attention of biological researchers and pharmacologists alike as a possible target for medical intervention. Here, we discuss the role GSH plays amongst these pathological conditions to illuminate how it can be used as a marker for human disease.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ageing; Cancer; Diabetes; Glutathione; HIV; Tuberculosis

Mesh:

Substances:

Year:  2018        PMID: 30342710     DOI: 10.1016/bs.acc.2018.07.004

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN: 0065-2423            Impact factor:   5.394


  42 in total

1.  Mechanistic Biomarkers in Toxicology

Authors:  Sonia Sanajou; Gönül Şahin
Journal:  Turk J Pharm Sci       Date:  2021-06-18

2.  The Role of Redox Status Changes in Dexamethasone-Induced Apoptosis in Jurkat Tumor Cells.

Authors:  О L Nosareva; E A Stepovaya; E V Shakhristova; R M Karpov
Journal:  Bull Exp Biol Med       Date:  2022-02-17       Impact factor: 0.804

Review 3.  Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives.

Authors:  Adriana A Garcia; Ana Koperniku; Julio C B Ferreira; Daria Mochly-Rosen
Journal:  Trends Pharmacol Sci       Date:  2021-08-10       Impact factor: 17.638

Review 4.  Effects of Probiotic Intervention on Markers of Inflammation and Health Outcomes in Women of Reproductive Age and Their Children.

Authors:  Kah Onn Kwok; Lisa R Fries; Irma Silva-Zolezzi; Sagar K Thakkar; Alison Iroz; Carine Blanchard
Journal:  Front Nutr       Date:  2022-06-06

5.  Mouse Subcutaneous BCG Vaccination and Mycobacterium tuberculosis Infection Alter the Lung and Gut Microbiota.

Authors:  Fabiola Silva; Raphaël Enaud; Elizabeth Creissen; Marcela Henao-Tamayo; Laurence Delhaes; Angelo Izzo
Journal:  Microbiol Spectr       Date:  2022-06-02

6.  L-GSH Supplementation in Conjunction With Rifampicin Augments the Treatment Response to Mycobacterium tuberculosis in a Diabetic Mouse Model.

Authors:  Abrianna Beever; Nala Kachour; James Owens; Kayvan Sasaninia; Afsal Kolloli; Ranjeet Kumar; Santhamani Ramasamy; Christina Sisliyan; Wael Khamas; Selvakumar Subbian; Vishwanath Venketaraman
Journal:  Front Pharmacol       Date:  2022-06-24       Impact factor: 5.988

Review 7.  Cysteine Depletion, a Key Action to Challenge Cancer Cells to Ferroptotic Cell Death.

Authors:  Boutaina Daher; Milica Vučetić; Jacques Pouysségur
Journal:  Front Oncol       Date:  2020-05-07       Impact factor: 6.244

Review 8.  KEAP1, a cysteine-based sensor and a drug target for the prevention and treatment of chronic disease.

Authors:  Sharadha Dayalan Naidu; Albena T Dinkova-Kostova
Journal:  Open Biol       Date:  2020-06-24       Impact factor: 6.411

9.  Carnosine Activates Cellular Stress Response in Podocytes and Reduces Glycative and Lipoperoxidative Stress.

Authors:  Maria Scuto; Angela Trovato Salinaro; Sergio Modafferi; Alessandra Polimeni; Tilman Pfeffer; Tim Weigand; Vittorio Calabrese; Claus Peter Schmitt; Verena Peters
Journal:  Biomedicines       Date:  2020-06-26

10.  Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes.

Authors:  Kimberly To; Ruoqiong Cao; Aram Yegiazaryan; James Owens; Timothy Nguyen; Kayvan Sasaninia; Charles Vaughn; Mohkam Singh; Edward Truong; Albert Medina; Edith Avitia; Jose Villegas; Christal Pham; Airani Sathananthan; Vishwanath Venketaraman
Journal:  Front Cell Infect Microbiol       Date:  2021-06-03       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.